In the news | 28th March 2022
Life science companies need to harness the predictive value of data to drive deeper process understanding. Here's how.
As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs? Establishing a strong digital backbone is the first critical step. Learn more from Claire Hill, IDBS’ BPLM market engagement lead, in this article published in BioIT World.